Transcription of Cell-Free Fetal DNA Testing - UHCprovider.com
{{id}} {{{paragraph}}}
Example: bankruptcy
Cell-Free Fetal DNA Testing - UHCprovider.com
Cell-Free Fetal DNA Testing Page 1 of 41 UnitedHealthcare Commercial Medical Policy Effective 07/01/2022 Proprietary Information of UnitedHealthcare. Copyright 2022 United HealthCare Services, Inc. UnitedHealthcare Commercial Medica l Policy Cell-Free Fetal DNA Testing Policy Number: 2022T0560Y Effective Date: July 1, 2022 Instructions for Use Table of Contents Page Coverage Rationale .. 1 Documentation Requirements .. 2 Definitions .. 2 Applicable Codes .. 3 Description of Services .. 8 Clinical 8 Food and Drug 35 References .. 35 Policy History/Revision Information .. 41 Instructions for 41 Coverage Rationale DNA-based noninvasive prenatal tests of Fetal Aneuploidy are proven and medically necessary as screening tools for Trisomy 21 (Down syndrome ), Trisomy 18 (Edwards syndrome ) or Trisomy 13 (Patau syndrome ) for individuals with a singleton pregnancy in any one of the following circumstances: Maternal age or oocyte age of 35 years or older at
One example is mosaic Turner syndrome, where some cells are 46, XX and others are 45, X due to the loss of a chro mosome (Genetics Home Reference, 2018d). Next Generation Sequencing (NGS) : New sequencni g techniques that can quickly analyze multpi le …
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: